Novartis AG (NVS)

Novartis AG Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	13,393	7,517	12,407	9,658	11,112
Short-Term Investments	1,035	11,413	15,922	1,905	334
Cash & Cash Equivalents	14,428	18,930	28,329	11,563	11,446
Cash Growth	-23.78%	-33.18%	145.00%	1.02%	-28.30%
Receivables	7,107	8,066	8,005	8,217	8,301
Inventory	5,913	7,175	6,666	7,131	5,982
Other Current Assets	3,033	2,739	2,718	2,762	3,775
Total Current Assets	30,481	36,910	45,718	29,673	29,504
Property, Plant & Equipment	10,924	12,195	13,106	13,939	13,746
Long-Term Investments	2,812	2,554	3,241	12,533	11,162
Goodwill and Intangibles	50,220	60,945	63,777	66,808	55,311
Other Long-Term Assets	5,508	4,849	5,953	4,825	8,647
Total Long-Term Assets	69,464	80,543	86,077	98,105	88,866
Total Assets	99,945	117,453	131,795	127,778	118,370
Accounts Payable	4,926	5,146	5,553	5,403	5,424
Current Debt	6,405	6,182	6,570	10,071	7,277
Other Current Liabilities	15,059	17,328	18,085	17,585	15,563
Total Current Liabilities	26,390	28,656	30,208	33,059	28,264
Long-Term Debt	20,034	21,782	24,523	27,978	22,056
Other Long-Term Liabilities	6,771	7,592	9,242	10,075	12,499
Total Long-Term Liabilities	26,805	29,374	33,765	38,053	34,555
Total Liabilities	53,195	58,030	63,973	71,112	62,819
Total Debt	26,439	27,964	31,093	38,049	29,333
Debt Growth	-5.45%	-10.06%	-18.28%	29.71%	-8.76%
Shareholders' Equity	46,667	59,342	67,655	56,598	55,474
Net Cash / Debt	-12,011	-9,034	-2,764	-26,486	-17,887
Net Cash Per Share	-5.82	-4.20	-1.23	-11.54	-7.71
Working Capital	4,091	8,254	15,510	-3,386	1,240
Book Value Per Share	22.76	27.80	30.24	24.86	24.21

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).